<?xml version="1.0" encoding="iso-8859-1"?>
<?xml-stylesheet type="text/xsl" href="http://www.physorg.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0">
<channel>
<title>PHYSorg.com: PHYSorg news tagged with: alpha</title>
<link>http://www.physorg.com/</link>
<language>en-us</language> 
<description>Physorg.com internet news portal provides the latest news on science including: Physics, Nanotechnology, Life Sciences, Space Science, Earth Science, Environment, Health and Medicine.</description>

 <item>
     <title>Gene therapy makes mice breath easier</title>
   	 <description>Researchers from Boston University School of Medicine (BUSM) have discovered a new gene therapy that may prevent the progression of emphysema. The study, which appears on-line in the Journal of Clinical Investigation, describes a method to express therapeutic genes in lung tissue for a lifetime after only a single treatment.</description>
     <link>http://www.physorg.com/news180638416.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 21 Dec 2009 17:30:04 EST</pubDate>
	 <guid isPermaLink="false">news180638416</guid>
</item>
<item>
     <title>Alarming trend -- antiviral therapy to treat hepatitis C is declining in the US</title>
   	 <description>Researchers from the University of Michigan determined that only 663,000 of the approximately 3.9 million Americans with hepatitis C virus (HCV) infection received antiviral therapy between 2002 and 2007.  Treatment rates appear to be declining, in part because only half of the patients know they are infected.  If this disturbing trend continues, by 2030 less than 15% of liver-related deaths from HCV will be prevented by antiviral therapy.  This study, the first to analyze nationwide practice patterns for HCV treatment, is published in the December issue of Hepatology, a journal of the American Association for the Study of Liver Diseases.</description>
     <link>http://www.physorg.com/news178264993.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Tue, 24 Nov 2009 06:50:01 EST</pubDate>
	 <guid isPermaLink="false">news178264993</guid>
</item>
<item>
     <title>Researchers Identify Gene Mutations Underlying Risk for Most Common Form of Parkinson's Disease</title>
   	 <description>(PhysOrg.com) -- Two genes containing mutations known to cause rare familial forms of parkinsonism are also associated with the more common, sporadic form of the disease where there is no family history, researchers have found.</description>
     <link>http://www.physorg.com/news177683398.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Tue, 17 Nov 2009 13:00:03 EST</pubDate>
	 <guid isPermaLink="false">news177683398</guid>
</item>
<item>
     <title>FDA-approved drugs eliminate, prevent cervical cancer in mice</title>
   	 <description>Researchers at the University of Wisconsin-Madison School of Medicine and Public Health have eliminated cervical cancer in mice with two FDA-approved drugs currently used to treat breast cancer and osteoporosis.</description>
     <link>http://www.physorg.com/news177008338.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 09 Nov 2009 17:10:02 EST</pubDate>
	 <guid isPermaLink="false">news177008338</guid>
</item>
<item>
     <title>High-performance plasmas may make reliable, efficient fusion power a reality</title>
   	 <description>In the quest to produce nuclear fusion energy, researchers from the DIII-D National Fusion Facility have recently confirmed long-standing theoretical predictions that performance, efficiency and reliability are simultaneously obtained in tokamaks, the leading magnetic confinement fusion device, operating at their performance limits. Experiments designed to test these predictions have successfully demonstrated the interaction of these conditions.</description>
     <link>http://www.physorg.com/news176402578.html</link>
	 <category>Physics</category>
	 <pubDate>Mon, 02 Nov 2009 17:30:03 EST</pubDate>
	 <guid isPermaLink="false">news176402578</guid>
</item>
<item>
     <title>'Spaghetti' scaffolding could help grow skin in labs</title>
   	 <description>Scientists are developing new scaffolding technology which could be used to grow tissues such as skin, nerves and cartilage using 3D spaghetti-like structures. Their research is highlighted in the latest issue of Business, the quarterly highlights magazine of the Biotechnology and Biological Sciences Research Council.</description>
     <link>http://www.physorg.com/news174906941.html</link>
	 <category>Chemistry</category>
	 <pubDate>Fri, 16 Oct 2009 10:30:01 EST</pubDate>
	 <guid isPermaLink="false">news174906941</guid>
</item>
<item>
     <title>Lunar Reconnaissance Orbiter's LAMP shedding light on permanently shadowed regions of the moon</title>
   	 <description>NASA's Lunar Reconnaissance Orbiter (LRO), launched on June 18 of this year, has begun its extensive exploration of the lunar environment and will return more data about the Moon than any previous mission. The Lyman-Alpha Mapping Project (LAMP), developed by Southwest Research Institute, is an integral part of the LRO science investigation. LAMP uses a novel method to peer into the perpetual darkness of the Moon's so-called permanently shadowed regions.</description>
     <link>http://www.physorg.com/news172413454.html</link>
	 <category>Space &amp; Earth</category>
	 <pubDate>Thu, 17 Sep 2009 13:50:03 EST</pubDate>
	 <guid isPermaLink="false">news172413454</guid>
</item>
<item>
     <title>Researchers aim to simplify a compound that acts on alpha-tubulin to slow down the process of cell division associated w</title>
   	 <description>Research is being carried out to design and synthesise a new generation of compounds that act on the tubulin molecule, involved in cell multiplication, through a mechanism that has not yet been used in chemotherapy. The researchers will then evaluate its anticarcinogenic potential for later application as a therapeutic treatment. This work is being done by the Organic Synthesis group of the Department of Inorganic and Organic Chemistry at the Universitat Jaume I (UJI) in Castell&amp;oacute;n, Spain. </description>
     <link>http://www.physorg.com/news171640001.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Wed, 09 Sep 2009 02:50:01 EST</pubDate>
	 <guid isPermaLink="false">news171640001</guid>
</item>
<item>
     <title>Gene variant heightens risk of severe liver disease in cystic fibrosis</title>
   	 <description>Researchers at the University of North Carolina at Chapel Hill have discovered a genetic risk factor for severe liver disease in people with cystic fibrosis. Those who carry a particular variant of the SERPINA1 gene (also known as alpha-1-antitrypsin or alpha-1-antiprotease) are five times more likely to develop cirrhosis and other liver complications than patients who carry the normal version of the gene.</description>
     <link>http://www.physorg.com/news171649546.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Tue, 08 Sep 2009 17:40:02 EST</pubDate>
	 <guid isPermaLink="false">news171649546</guid>
</item>
<item>
     <title>Arterial, venous or total mesenteric ischemia/reperfusion causes different types of injury?</title>
   	 <description>It is known that I/R induces an inflammatory response deleterious to the organ involved but also to the system as a whole. Mesenteric ischemia occurs when the veins or arteries that supply blood to the intestine are obstructed. In transplants, the organ undergoes total (arterial and venous) I/R. Few available treatments exist. Greater knowledge of these conditions would aid in the search for new therapies. However, the precise nature of the response arises after venous, arterial or total ischemia is not fully understood.</description>
     <link>http://www.physorg.com/news170499781.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Wed, 26 Aug 2009 14:10:04 EST</pubDate>
	 <guid isPermaLink="false">news170499781</guid>
</item>
<item>
     <title>New genes at work in patients with hereditary lung disease</title>
   	 <description>University of Florida researchers have safely given new, functional genes to patients with a hereditary defect that can lead to fatal lung and liver diseases, according to clinical trial findings slated to appear this week in the online early edition of the Proceedings of the National Academy of Sciences.</description>
     <link>http://www.physorg.com/news169140806.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 10 Aug 2009 17:10:03 EST</pubDate>
	 <guid isPermaLink="false">news169140806</guid>
</item>
<item>
     <title>Noninsulin-producing alpha cells in the pancreas can be converted to insulin-producing beta cells</title>
   	 <description>In findings that add to the prospects of regenerating insulin-producing cells in people with type 1 diabetes, researchers in Europe -- co-funded by the Juvenile Diabetes Research Foundation -- have shown that insulin-producing beta cells can be derived from non-insulin-producing cells in the pancreas.</description>
     <link>http://www.physorg.com/news168799882.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Thu, 06 Aug 2009 17:54:39 EST</pubDate>
	 <guid isPermaLink="false">news168799882</guid>
</item>
<item>
     <title>More insulin-producing cells, at the flip of a 'switch'</title>
   	 <description>Researchers have found a way in mice to convert another type of pancreas cell into the critical insulin-producing beta cells that are lost in those with type I diabetes. The secret ingredient is a single transcription factor, according to the report in the August 7th issue of Cell, a Cell Press journal.</description>
     <link>http://www.physorg.com/news168788864.html</link>
	 <category>Chemistry</category>
	 <pubDate>Thu, 06 Aug 2009 15:10:01 EST</pubDate>
	 <guid isPermaLink="false">news168788864</guid>
</item>
<item>
     <title>Possible Meteorite Imaged by Opportunity Rover</title>
   	 <description>(PhysOrg.com) -- The Opportunity rover has eyed an odd-shaped, dark rock, about 0.6 meters (2 feet) across on the surface of Mars, which may be a meteorite.</description>
     <link>http://www.physorg.com/news168534413.html</link>
	 <category>Space &amp; Earth</category>
	 <pubDate>Mon, 03 Aug 2009 16:30:02 EST</pubDate>
	 <guid isPermaLink="false">news168534413</guid>
</item>
<item>
     <title>Promising new trends in Web search engines</title>
   	 <description>	The Internet is a vastly different place than it was 15 years ago, but the way consumers search it has changed very little.</description>
     <link>http://www.physorg.com/news166903914.html</link>
	 <category>Technology</category>
	 <pubDate>Wed, 15 Jul 2009 22:20:01 EST</pubDate>
	 <guid isPermaLink="false">news166903914</guid>
</item>
<item>
     <title>Researchers Suggest New Approach in Development Efforts for Parkinson`s Therapeutics</title>
   	 <description>(PhysOrg.com) -- Researchers outline today a new approach in the potential development of drugs to counter a cellular defect that triggers Parkinson`s and other diseases.</description>
     <link>http://www.physorg.com/news166808908.html</link>
	 <category>Chemistry</category>
	 <pubDate>Tue, 14 Jul 2009 17:00:12 EST</pubDate>
	 <guid isPermaLink="false">news166808908</guid>
</item>
<item>
     <title>Interferon alpha can delay full onset of type I diabetes</title>
   	 <description>A low dose of oral interferon alpha shows promise in preserving beta cell function for patients with newly diagnosed type 1 diabetes, or juvenile diabetes, according to researchers at The University of Texas Medical School at Houston.</description>
     <link>http://www.physorg.com/news165656173.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Wed, 01 Jul 2009 09:10:01 EST</pubDate>
	 <guid isPermaLink="false">news165656173</guid>
</item>
<item>
     <title>Immunologists identify biochemical signals that help immune cells remember how to fight infection</title>
   	 <description>May 28, 2009 - Immunology researchers at UT Southwestern Medical Center have discovered how two biochemical signals play unique roles in promoting the development of a group of immune cells employed as tactical assassins.</description>
     <link>http://www.physorg.com/news162708029.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Thu, 28 May 2009 05:41:59 EST</pubDate>
	 <guid isPermaLink="false">news162708029</guid>
</item>
<item>
     <title>Star-Forming Backbone of a Massive Structure in the Early Universe Photographed</title>
   	 <description>(PhysOrg.com) -- Using a special camera known as AzTEC developed by a research team led by Grant Wilson, astronomy professor at the University of Massachusetts Amherst, an international research group has imaged a set of ultra-massive galaxies that are thought to form the backbone of a super large structure, or collection of galaxies congregated together, in the very early universe.</description>
     <link>http://www.physorg.com/news162059711.html</link>
	 <category>Space &amp; Earth</category>
	 <pubDate>Wed, 20 May 2009 17:35:44 EST</pubDate>
	 <guid isPermaLink="false">news162059711</guid>
</item>
<item>
     <title>Review: Flaws in Web's much-touted WolframAlpha</title>
   	 <description>(AP) --  When a free Web service called WolframAlpha launches in the coming days, the general public will get to try a "computational knowledge engine" that has had technology insiders buzzing because of its oracle-like ability to spit out answers and make calculations.</description>
     <link>http://www.physorg.com/news161441956.html</link>
	 <category>Technology</category>
	 <pubDate>Wed, 13 May 2009 13:59:51 EST</pubDate>
	 <guid isPermaLink="false">news161441956</guid>
</item>
<item>
     <title>Wolfram Alpha 'Knowledge Engine' is Like a Modern Farmer's Almanac</title>
   	 <description>(PhysOrg.com) -- Currently, there's a lot of hype and skepticism surrounding the latest "Google rival," a so-called search engine named Wolfram Alpha. In the near future, anyone with Internet access will be able to freely visit www.wolframalpha.com and investigate how it works. In a media webinar earlier today, Wolfram Alpha's creator, Stephen Wolfram, said the site should be launching "in a bit over a week."  Wolfram also showed off his ambitious project by demonstrating a variety of search queries and answering questions from journalists.</description>
     <link>http://www.physorg.com/news161024785.html</link>
	 <category>Technology</category>
	 <pubDate>Fri, 08 May 2009 19:44:35 EST</pubDate>
	 <guid isPermaLink="false">news161024785</guid>
</item>
<item>
     <title>Study pinpoints role of insulin on glucagon levels</title>
   	 <description>April 7, 2009 - Researchers at the Joslin Diabetes Center have shown for the first time that insulin plays a key role in suppressing levels of glucagon, a hormone involved in carbohydrate metabolism and regulating blood glucose levels.</description>
     <link>http://www.physorg.com/news158328265.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Tue, 07 Apr 2009 13:04:49 EST</pubDate>
	 <guid isPermaLink="false">news158328265</guid>
</item>
<item>
     <title>Nicotine may have more profound impact than previously thought</title>
   	 <description>Nicotine isn't just addictive. It may also interfere with dozens of cellular interactions in the body, new Brown University research suggests.</description>
     <link>http://www.physorg.com/news157987668.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Fri, 03 Apr 2009 14:28:23 EST</pubDate>
	 <guid isPermaLink="false">news157987668</guid>
</item>
<item>
     <title>Protein protects neurons in brain from damage due to inflammation</title>
   	 <description>A research team from the University of California, San Diego School of Medicine and the Salk Institute for Biological Studies in La Jolla has identified a protein in the brain of mice that protects neurons from excessive inflammation, which can lead to neurodegenerative disorders such as Parkinson's disease.  Their study, which identifies the protective function of a protein called Nurr1 and defines the pathway by which it works, will be published in the April 3 edition of the journal Cell.</description>
     <link>http://www.physorg.com/news157895578.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Thu, 02 Apr 2009 12:56:59 EST</pubDate>
	 <guid isPermaLink="false">news157895578</guid>
</item>
<item>
     <title>MRSA study suggests strategy shift needed to develop effective therapeutics</title>
   	 <description>USA300--the major epidemic strain of methicillin-resistant Staphylococcus aureus (MRSA) causing severe infections in the United States during the past decade--inherits its destructiveness directly from a forefather strain of the bacterium called USA500 rather than randomly acquiring harmful genes from other MRSA strains. This finding comes from a new study led by scientists at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.</description>
     <link>http://www.physorg.com/news156512182.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Tue, 17 Mar 2009 12:39:13 EST</pubDate>
	 <guid isPermaLink="false">news156512182</guid>
</item>
<item>
     <title>Wolfram Alpha Could Answer Questions that Google Can't</title>
   	 <description>(PhysOrg.com) -- A new search engine described as an "electronic brain" could make searching the Internet more intelligent. Called Wolfram Alpha, the search engine computes its own answers rather than looking them up in a large database, as Google and many other search engines currently do. With its computational abilities, Wolfram Alpha could lead to new types of questions, answers and computations that today's search engines can't handle.</description>
     <link>http://www.physorg.com/news155826981.html</link>
	 <category>Technology</category>
	 <pubDate>Mon, 09 Mar 2009 14:16:55 EST</pubDate>
	 <guid isPermaLink="false">news155826981</guid>
</item>
<item>
     <title>Study finds link between Parkinson's disease genes and manganese poisoning</title>
   	 <description>A connection between genetic and environmental causes of Parkinson's disease has been discovered by a research team led by Aaron D. Gitler, PhD, Assistant Professor in the Department of Cell and Developmental Biology at the University of Pennsylvania School of Medicine. Gitler and colleagues found a genetic interaction between two Parkinson's disease genes (alpha-synuclein and PARK9) and determined that the PARK9 protein can protect cells from manganese poisoning, which is an environmental risk factor for a Parkinson's disease-like syndrome. The findings appear online this week in Nature Genetics.</description>
     <link>http://www.physorg.com/news152720701.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Sun, 01 Feb 2009 14:25:21 EST</pubDate>
	 <guid isPermaLink="false">news152720701</guid>
</item>
<item>
     <title>Google Releases Chrome 2.0 Alpha</title>
   	 <description>(PhysOrg.com) -- With the full release of Chrome 1.0 in December, Google has just released Chrome 2.0 alpha that brings many noticeable improvements over Chrome 1.0. With this new alpha release of Chrome 2.0, the browser has been overhauled in which it handles HTTP.</description>
     <link>http://www.physorg.com/news151150870.html</link>
	 <category>Technology</category>
	 <pubDate>Wed, 14 Jan 2009 10:21:10 EST</pubDate>
	 <guid isPermaLink="false">news151150870</guid>
</item>
<item>
     <title>Potential therapy for congenital muscular dystrophy</title>
   	 <description>Current research suggests laminin, a protein that helps cells stick together, may lead to enhanced muscle repair in muscular dystrophy.  The related report by Rooney et al, "Laminin-111 restores regenerative capacity in a mouse model for alpha 7 integrin congenital myopathy," appears in the January 2009 issue of The American Journal of Pathology.</description>
     <link>http://www.physorg.com/news149838489.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Tue, 30 Dec 2008 05:48:09 EST</pubDate>
	 <guid isPermaLink="false">news149838489</guid>
</item>
<item>
     <title>Common treatment for chronic prostatitis fails to reduce symptoms</title>
   	 <description>Alfuzosin, a drug commonly prescribed for men with chronic prostatitis, a painful disorder of the prostate and surrounding pelvic area, failed to significantly reduce symptoms in recently diagnosed men who had not been previously treated with this drug, according to a clinical trial sponsored by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the National Institutes of Health (NIH). The study is to be published in the New England Journal of Medicine.</description>
     <link>http://www.physorg.com/news148818190.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Thu, 18 Dec 2008 10:23:10 EST</pubDate>
	 <guid isPermaLink="false">news148818190</guid>
</item>


</channel>
</rss>

